Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

HHS Logo Eagle IconU.S. Department of Health and Human Services

Office of Health Policy (HP)

The Office of Health Policy (HP) provides a cross-cutting perspective that bridges Departmental programs, state, local, and private sector activities, and the research community, in order to develop, analyze, coordinate and inform leadership on health policy issues for the Secretary. HP carries out this mission by conducting policy and economic and budget analyses, assisting in the development and review of regulations, budgets, legislation, and survey design efforts, as well as conducting and coordinating research, evaluation, and information dissemination on issues relating to health policy.

HP is organized in four divisions that align with major Department programs:

Division of Health Care Financing Policy (HFP)
Division of Public Health Services (PHS)
Division of Health Care Quality and Outcomes (HQO)
Division of Health Care Access and Coverage (HAC)

Health Policy Research:

  • Reports to Congress
  • Research & Issue Briefs
  • HP Authored or Sponsored Work Published in Journals

Other Helpful Information:

Topic Areas:

Contact Us: ASPEHealthPolicy@hhs.gov

Reports

Displaying 1 - 10 of 542. 10 per page. Page 1.

Advanced Search
ASPE Issue Brief

Trends in Medicaid and CHIP Telehealth Part III: Telehealth Utilization Trends Among Child Enrollees, 2019-2021

This report examines national trends in telehealth service delivery to enrollees ages 0-18 years from 2019 to 2021, by enrollee characteristics such as age group and race and ethnicity. Services delivered via telehealth to pediatric Medicaid and CHIP enrollees rapidly expanded with the onset of the COVID-19 Public Health Emergency (PHE) in 2020 and remained higher than pre-PHE levels in 2021.
ASPE Issue Brief

Postpartum Health Care Use in Medicaid During the COVID-19 Public Health Emergency: Implications for Extending Postpartum Coverage

This Issue Brief provides a descriptive analysis of postpartum health care use among the Medicaid population before and during the PHE, when the continuous enrollment condition was in effect.
ASPE Issue Brief

Drug Competition Series: Analysis of New Generic Markets Effect of Market Entry on Generic Drug Prices: Medicare Data 2007-2022

The U.S. has a number of policies related to drug pricing, affordability, and availability. To encourage manufacturers to innovate with new therapies, patent policy rewards the creation of new branded medicines. As those patents come to an end, generic drug manufacturers may enter a market and seek to sell their products at lower prices than the competing brand drugs.
ASPE Issue Brief

The Impact of Alternative Payment Models on Medicare Spending and Quality, 2012-2022

We evaluated both the Center for Medicare and Medicaid Services Innovation Center (CMS Innovation Center) models and the Medicare Shared Savings Program (MSSP) and found that they have generated gross savings for all beneficiaries in the Traditional Medicare program while demonstrating positive impacts on selected quality measures.
ASPE Issue Brief

Medicare Part B Enrollee Use and Spending on Biosimilars, 2018-2023

Biosimilars provide competition for biologics, which account for a significant and growing portion of Medicare Part B drug spending. This report evaluates the current state of biosimilar competition in Medicare Part B and explores opportunities to achieve further savings.
ASPE Issue Brief

Inflation Reduction Act Research Series: Projecting the Impact of the $2,000 Part D Out-Of-Pocket Cap for Medicare Part D Enrollees with High Prescription Drug Spending

The Inflation Reduction Act includes many provisions that aim to reduce out-of-pocket spending for prescription drugs covered under Medicare Part D. In 2024, cost-sharing in the final phase of the Part D benefit, the catastrophic coverage phase, was eliminated.
Report

Building the Data Capacity for Patient-Centered Outcomes Research: The 2024 Annual Report and Infographic

The 2024 Office of the Secretary Patient-Centered Outcomes Research Trust Fund (OS-PCORTF) Annual Report highlights the data infrastructure accomplishments of over 40 multi-agency projects on topics of national importance such as maternal health, substance use disorder and intellectual and developmental disabilities.
ASPE Issue Brief

Health Insurance Coverage and Healthcare Access from 2021-2024

This Issue Brief investigates how health insurance coverage, as well as healthcare access and affordability, has changed in recent years, with an emphasis on policies implemented from 2021 to 2024. Over 300 million Americans now have health insurance coverage. The U.S. uninsured rate has fallen significantly over the past four years.
Report

Assessing the Feasibility of Creating a National Behavioral Health Workforce Database

The U.S. behavioral health (BH) workforce faces significant shortages and distribution disparities, hindering access to quality care and worsening health outcomes. A comprehensive, centralized database of BH providers is vital for advancing patient-centered outcomes research (PCOR), comparative effectiveness research (CER), and evidence-based policymaking.
Report

The Implications of the No Surprises Act on Contract Dynamics, Negotiations, and Finances

To explore whether and how the NSA has affected insurer-provider dynamics, contract negotiations, and payment rates, the Office of the Assistant Secretary for Planning and Evaluation (ASPE) asked RAND to conduct discussions with stakeholders. In this report, RAND summarizes the approach exploring these topics, the themes that emerged from our discussions, and areas for additional inquiry.